Resound Nexia Expert Review

The ReSound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.87/5, ranking #21 among 35 prescription hearing aids tested.

The Nexia delivers solid speech clarity in quiet environments, scoring 3.8/5—0.37 points above the category average. It also excels in feedback handling with a perfect 5.0/5 score and provides notably comfortable own-voice perception at 3.6/5, which is 0.87 points above average for prescription devices. These strengths make it well-suited for conversations in calm settings and for wearers sensitive to hearing their own voice.

However, the Nexia shows significant limitations in noisy environments. Its speech-in-noise score of 0.4/5 falls 1.13 points below the category average—a substantial gap that prospective buyers should consider carefully. Music streaming performance is mixed at 2.8/5, slightly above average but modest in absolute terms.

At this price point, several competitors in the same premium tier deliver stronger overall performance, including the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5). The Nexia may appeal to those who prioritize quiet-environment clarity and own-voice comfort over noise management, but shoppers seeking balanced performance across listening situations should compare alternatives before deciding.